Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
ACS Chem Neurosci ; 13(17): 2599-2612, 2022 09 07.
Article in English | MEDLINE | ID: mdl-36007056

ABSTRACT

TDP-43 proteinopathies cover a range of neurodegenerative diseases, including frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS). Hyperphosphorylated TDP-43 was found within the inclusion bodies in disease lesions; however, the role of hyperphosphorylation and the toxic species are still ambiguous. To characterize the hyperphosphorylation effect of TDP-43, here, we employed five serine mutations implicated in the diseases at serine locations 379, 403, 404, 409, and 410 in the C-terminus to aspartate (S5D) and to alanine (S5A). We systematically characterized the conformation, liquid-liquid phase separation, oligomerization, and fibrillization of TDP-43 variants. Results revealed that the recombinant TDP-43 variants readily formed structurally similar spherical oligomers, as evidenced by circular dichroism spectroscopy, fluorescence spectroscopy, the TDP-43 oligomer-specific antibody assay, dynamic light scattering, and transmission electron microscopy. After incubation, only the phosphor-mimic S5D TDP-43 formed thioflavin-positive amyloid fibrils, whereas wild-type and S5A TDP-43 formed amorphous aggregates. We also examined membrane disruption, the cytotoxicity of human neuroblastoma, and the synaptic loss of primary neurons induced by oligomers and large aggregates of TDP-43. The results showed that all oligomeric TDP-43 variants were toxic regardless of hyperphosphorylation, but the fibrils and amorphous aggregates were not. Overall, our results demonstrated the hyperphosphorylation effect on fibril formation and the toxicity attributed from TDP-43 oligomers. This study facilitates the understanding and therapeutic development for TDP-43 proteinopathies.


Subject(s)
Amyloidosis , Amyotrophic Lateral Sclerosis , TDP-43 Proteinopathies , Amyloid/chemistry , Amyloidogenic Proteins , Amyotrophic Lateral Sclerosis/genetics , DNA-Binding Proteins/genetics , Humans , Neurons/pathology , Serine , TDP-43 Proteinopathies/genetics
2.
Nat Commun ; 5: 4824, 2014 Sep 12.
Article in English | MEDLINE | ID: mdl-25215604

ABSTRACT

Proteinaceous inclusions are common hallmarks of many neurodegenerative diseases. TDP-43 proteinopathies, consisting of several neurodegenerative diseases, including frontotemporal lobar dementia (FTLD) and amyotrophic lateral sclerosis (ALS), are characterized by inclusion bodies formed by polyubiquitinated and hyperphosphorylated full-length and truncated TDP-43. The structural properties of TDP-43 aggregates and their relationship to pathogenesis are still ambiguous. Here we demonstrate that the recombinant full-length human TDP-43 forms structurally stable, spherical oligomers that share common epitopes with an anti-amyloid oligomer-specific antibody. The TDP-43 oligomers are stable, have exposed hydrophobic surfaces, exhibit reduced DNA binding capability and are neurotoxic in vitro and in vivo. Moreover, TDP-43 oligomers are capable of cross-seeding Alzheimer's amyloid-ß to form amyloid oligomers, demonstrating interconvertibility between the amyloid species. Such oligomers are present in the forebrain of transgenic TDP-43 mice and FTLD-TDP patients. Our results suggest that aside from filamentous aggregates, TDP-43 oligomers may play a role in TDP-43 pathogenesis.


Subject(s)
Amyloid/chemistry , Cerebral Cortex/pathology , DNA-Binding Proteins/chemistry , Frontotemporal Dementia/pathology , Protein Aggregation, Pathological/pathology , TDP-43 Proteinopathies/pathology , Amino Acid Sequence , Amyloid/immunology , Animals , Antibodies, Monoclonal/biosynthesis , Antibodies, Monoclonal/chemistry , Cell Line, Tumor , Cerebral Cortex/chemistry , Cerebral Cortex/immunology , DNA-Binding Proteins/genetics , DNA-Binding Proteins/immunology , Embryo, Mammalian , Epitopes/chemistry , Epitopes/immunology , Escherichia coli/genetics , Escherichia coli/metabolism , Frontotemporal Dementia/genetics , Frontotemporal Dementia/immunology , Gene Expression , HEK293 Cells , Humans , Injections, Intraventricular , Male , Mice , Molecular Sequence Data , Neurons/chemistry , Neurons/immunology , Neurons/pathology , Primary Cell Culture , Protein Aggregates , Protein Aggregation, Pathological/genetics , Protein Aggregation, Pathological/immunology , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/immunology , TDP-43 Proteinopathies/genetics , TDP-43 Proteinopathies/immunology
3.
Article in English | MEDLINE | ID: mdl-19162949

ABSTRACT

The forms of the medical records are different from one institute to another. Moreover, medical records are always stored in free text. Consequently, medical records almost can not be logically analyzed and understood by machines. In this paper, we have applied the information retrieval (IR) technique in the using of medical records. We have implemented an IR system for the users, such as doctors and patients, to query similar or related medical records to support diagnosis and treatment. Knowledge retrieval for reuse is the key idea of this system.


Subject(s)
Information Systems/standards , Medical Records Systems, Computerized/standards , Software , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...